Mastery EAQ Ch. 20

A  Administer 30 minutes before meals.

B  Administer after dissolving in water.

C  Administer after meals.

D  Administer with fruit juices.

A  Hyperthyroidism, Coronary artery disease, Emphysema, Type 2 diabetes mellitus

B  Emphysema, Type 2 diabetes mellitus, Parkinsonism, Hyperthyroidism,

C  Peptic ulcer, Parkinsonism, Hyperthyroidism, Coronary artery disease

D  Emphysema, Type 2 diabetes mellitus, Peptic ulcer, Parkinsonism,

A  “This medication will increase your ability to sleep without dreaming.”

B  “You will only need to take this medication for 3 months.”

C  “This medication will enhance your memory.”

D  “This medication should cure your Alzheimer’s disease.”

A  Lidocaine

B  Atropine

C  Epinephrine

D  Dopamine

A  Pupil constriction

B  Decreased heart rate

C  Elevated heart rate

D  Pupil dilation

A  Relief of dry skin

B  Increased muscle strength

C  Moist oral mucous membranesn

D  Improved vision

A  Able to walk long distances

B  Improved memory

C  Increased muscle strength

D  No longer dizzy

A  Hypertension and Syncope

B  Hair loss and Constipation

C  Hair loss and Mydriasis

D  Constipation and Mydriasis

A  Assessment of blood pressure

B  Administration of another dose in an hour

C  Administration of a second drug

D  Assessment of bowel sounds

A  Decreased gastric motility and Pupil dilation

B  Pupil dilation and Decreased sweat gland secretion

C  Decreased heart rate and Increased respiratory secretions

D  Decreased gastric motility and Decreased sweat gland secretion

A  “I will review any over-the-counter medications with my health care provider.”

B  “I hope to feel improvement in muscle strength.”

C  “The medical alert in my health care record should cover me.”

D  “I will take the medication 30 minutes before meals.”

A  Increased responsibility for self-care

B  Limit sleep during the day

C  A walking program at least once a week

D  Add more stimuli to the environment

A  Cardiovascular status, Pain assessment, Complete blood count, Neurologic status

B  Pain assessment, Complete blood count, Gastrourinary (GU) status, Assess for suicidal tendencies

C  Cardiovascular status, Gastrourinary (GU) status, Pain assessment, Complete blood count

D  Neurologic status, Cardiovascular status, Gastrourinary (GU) status, Assess for suicidal tendencies

A  Ataxia and Cramps

B  Bleeding and Cramps

C  Ataxia and Bleeding

D  Diarrhea and Syncope

A  Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Stop the medication if you have headaches.

B  Get up slowly. Eat something if you feel nauseated. Stop the medication if you have headaches. Tell your health care provider if you have stomach pains.

C  Stop the medication if you have headaches. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

D  Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

A  Peptic ulcer and nonobstructive urinary retention

B  Decreased urination with possible renal calculi

C  Urinary retention from neurogenic atony of the bladder

D  Post orthopedic surgery, low urinary output and bronchial wheezing

A  An antidote to tricyclic antidepressant toxicity. Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation

B  Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation. An antidote in biochemical warfare

C  Relieve severe constriction of the bronchioles. Diagnose and treat myasthenia gravis. Treat a patient with a prolonged history of sleep deprivation

D  Diagnose and treat myasthenia gravis. An antidote in biochemical warfare. An antidote to tricyclic antidepressant toxicity

A  “Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”
“Get up slowly from a sitting or lying position.”

B  “Tell your health care provider if you have gastric pain that does not subside.”
“Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”

C  “Your drug dose will be gradually increased.”
“Get up slowly from a sitting or lying position.”
“Tell your health care provider if you have gastric pain that does not subside.”

D  “Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”
“Your drug dose will be gradually increased.”

A  7 mg

B  10 mg

C  18 mg

D  12 mg

A  Inject bethanechol. Administer atropine. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

B  Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

C  Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Administer atropine. Increase fluid intake as tolerated.

D  Administer atropine. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

A  Bronchoconstriction, Hypoglycemia, Hypothyroidism

B  Dyspnea, Bronchoconstriction, Orthostatic hypotension

C  Hypoglycemia, Hypothyroidism, Dyspnea

D  Orthostatic hypotension, Hypoglycemia, Hypothyroidism

A  7 mg

B  2 mg

C  5 mg

D  10 mg

A  Cognitive stabilization for a few months

B  Gradual decrease in cognitive function

C  Temporary improvement in cognitive skills

D  Rapid cognitive changes with decline

A  Nicotinic-receptor stimulation causes increased contraction of skeletal muscle. Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels.

B  Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Nicotinic-receptor stimulation causes increased blood pressure.

C  Nicotinic-receptor stimulation causes increased blood pressure. Muscarinic-receptor stimulation causes increased gastrointestinal motility. Nicotinic-receptor stimulation causes increased contraction of skeletal muscle.

D  Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Muscarinic-receptor stimulation causes increased gastrointestinal motility.

A  “Take the medication 30 minutes after eating.”

B  “Notify your health care provider if you have a headache.”

C  “Seek medical help if you develop nausea and vomiting.”

D  “Do not eat solid food.”

A  Emphysema, Psoriatic arthritis.

B  Emphysema, Hypothyroidism

C  Hypothyroidism, Psoriatic arthritis.

D  Asthma, Coronary artery disease

A  Ataxia, Insomnia, Dyspnea

B  Ataxia, Dyspnea, Hypotension

C  Gastrointestinal (GI) upset, Ataxia, Dyspnea

D  Insomnia, Hypotension, Gastrointestinal (GI) upset

A  “Let me assess what other medications the patient is taking.”

B  “Sometimes family members aren’t the best at assessing these things.”

C  “I will call the health care provider and ask for the medication to be changed.”

D  “The medication has an onset of action of about 3 weeks.”

A  Blood glucose level

B  Body mass index

C  Vital signs

D  Bowel sounds

A  Galantamine

B  Rivastigmine

C  Donepezil

D  Memantine

A  Increase fluid intake to increase blood volume.

B  Move from a sitting to standing position slowly.

C  Call for someone before rising.

D  Take ibuprofen before rising.

A  Memantine

B  Edrophonium

C  Bethanechol

D  Physostigmine

A  Heart rate 30 beats/min

B  Blood pressure 150/95 mm Hg

C  Constipation

D  Respiratory rate 24 breaths/min

A  “I feel like I am coughing up more phlegm.”

B  “I can tell my muscle strength has gotten better.”

C  “I have noticed that I have been urinating more frequently.”

D  “My family says that my memory has improved.”

A  “Do not drink grapefruit juice while on this medication.”

B  “Be cautious with activity until you know how the medication affects you.”

C  “Do not take this medication with food.”

D  “You will take this medication once per week.”

A  Donepezil, Neostigmine, Memantine

B  Physostigmine, Donepezil, Memantine

C  Donepezil, Memantine, Pyridostigmine

D  Neostigmine, Pyridostigmine, Physostigmine

A  Inability to sleep

B  Respiratory rate 30 breaths/min

C  Raised, erythematous rash

D  Blood pressure 70/40 mm Hg

A  Sweating, Dizziness, Dry cough, Hypotension

B  Dry cough, Dizziness, Bradycardia, Hypotension

C  Sweating, Dizziness, Bradycardia, Dry cough

D  Sweating, Dizziness, Bradycardia, Hypotension

A  Dextrose solution intravenously

B  Physostigmine intravenously

C  A high dose of donepezil orally

D  An antihistamine intravenously

A  Urinary

B  Neurologic

C  Gastrointestinal

D  Musculoskeletal

A  Galantamine and Edrophonium

B  Neostigmine and Edrophonium

C  Neostigmine and Galantamine

D  Pilocarpine and Succinylcholine

A  Urination

B  Increased cognition

C  Relaxed muscles

D  Wakefulness

A  Chronic refractory heartburn

B  Gastric atony

C  Hyperthyroidism

D  Urinary retention

A  Memantine

B  Donepezil

C  Bethanechol

D  Pyridostigmine

A  Intravenous

B  Ocular

C  Intramuscular

D  Oral

A  Measure the patient’s urinary output.

B  Administer epinephrine.

C  Assess the patient’s breath sounds.

D  Monitor the patient’s heart rate.

A  Succinylcholine

B  Cevimeline

C  Bethanechol

D  Donepezil

A  Atropine

B  Memantine

C  Epinephrine

D  Rivastigmine

A  Neostigmine

B  Rivastigmine

C  Succinylcholine

D  Pilocarpine

A  Echothiophate

B  Donepezil

C  Pyridostigmine

D  Atropine

A  Physostigmine

B  Tacrine

C  Carbachol

D  Memantine

A  Dry eye syndrome

B  Cataracts

C  Macular degeneration

D  Glaucoma

A  Memantine

B  Donepezil

C  Atropine

D  Rivastigmine

A  Postoperative ischemic colitis

B  Respiratory atelectasis

C  Urinary atony

D  Postoperative hypotension

A  Ability to swallow without difficulty

B  Increased arm strength

C  Decreased respiration

D  Ability to speak clearly

A  Limit sleep during the day

B  Add more stimuli to the environment

C  Increased responsibility for self-care

D  A walking program at least once a week

A  “I will review any over-the-counter medications with my health care provider.”

B  “I will take the medication 30 minutes before meals.”

C  “The medical alert in my health care record should cover me.”

D  “I hope to feel improvement in muscle strength.”

A  Atropine available for immediate use. Electroencephalogram ready to place. Telemetry monitor on the patient. Blood pressure equipment for frequent monitoring.

B  Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient.Blood pressure equipment for frequent monitoring.

C  Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient. Electroencephalogram ready to place.

D  Atropine available for immediate use. Epinephrine available for immediate use. Electroencephalogram ready to place. Blood pressure equipment for frequent monitoring.

A  Nausea and Apical pulse of 56 beats per minute

B  Urinary retention and Hypoactive bowel sounds

C  Dry mouth and Hypoactive bowel sounds

D  Urinary retention and Dry mouth

A  Nasal spray

B  Subcutaneous infusions

C  Oral disintegrating tablets

D  Liquid oral solutions